Contraction of airway smooth muscle (ASM) plays an important role in the regulation of air flow and is potentially involved in the pathophysiology of certain respiratory diseases. Extracellular nucleotides regulate ASM contraction via purinergic receptors, but the signaling mechanisms involved are not fully understood. Uridine adenosine tetraphosphate (Up 4A) contains both pyrimidine and purine moieties, which are known to potentially activate P2X and P2Y receptors. Both P2X and P2Y receptors have been identified in the lung, including airway epithelial cells and ASM. We report here a study of purinergic signaling in the respiratory system, with a focus on the effect of Up 4A on ASM contraction. Up 4A induced contraction of rat isolated trachea and extrapulmonary bronchi as well as human intrapulmonary bronchioles. Up 4A-induced contraction was blocked by di-inosine pentaphosphate, a P2X antagonist, but not by suramin, a nonselective P2 antagonist. Up 4A-induced contraction was also attenuated by ␣,␤-methylene-ATP-mediated P2X receptor desensitization. Several P2X receptors were detected at the mRNA level: P2X1, P2X4, P2X6, and P2X7, and to a lesser extent P2X3. Furthermore, the Up 4A response was inhibited by removal of extracellular Ca 2ϩ and by the presence of the L-type Ca 2ϩ channel blocker, nifedipine, or the Rho-associated kinase inhibitor, H1152. We conclude that Up 4A stimulates ASM contraction, and the underlying signaling mechanism appears to involve P2X (most likely P2X1) receptors, extracellular Ca 2ϩ entry via L-type Ca 2ϩ channels, and Ca 2ϩ sensitization through the RhoA/Rhoassociated kinase pathway. This study will add to our understanding of the pathophysiological roles of extracellular nucleotides in the lung.
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Abundant evidence suggests that purinergic signaling plays an important role in the pathophysiology of asthma and COPD (1, 28) . Extracellular nucleotides, such as ATP, ADP, and UTP, released from a variety of cells of the respiratory system, cannot only stimulate secretion of anion, surfactant, and cytokines, but also induce Ca 2ϩ mobilization in smooth muscle cells and thus regulate airway tone (1) . Extracellular nucleotides initiate their effects by acting on membrane purinergic P2X and P2Y receptors, both of which have been identified in the lung (21, 35, 36) . P2X receptors are ligand-gated ion channels, whereas P2Y receptors are G protein-coupled receptors (29) . In rat and guinea pig ASM, P2X receptors have been shown to mediate ATP-stimulated airway constriction via regulation of Ca 2ϩ influx (9, 25) . On the other hand, in mouse lung slices, P2Y receptors have been found to mediate ATPinduced contraction through stimulation of extracellular Ca 2ϩ entry (4, 8) . In addition, P2X receptor-mediated ASM contraction involves Ca 2ϩ sensitization via activation of the RhoA/ ROCK pathway (16, 27) . However, the effects of dinucleotides on ASM and the underlying signaling mechanisms are largely unknown.
Uridine adenosine tetraphosphate (Up 4 A) contains both purine and pyrimidine moieties, which are known to potentially activate P2X and P2Y receptors. Up 4 A was recently identified as a novel endothelium-derived vasoconstrictive factor and is present at effective concentrations in human plasma (18) . Up 4 A can be released from endothelial cells by a variety of stimuli, such as acetylcholine (ACh), endothelin, ATP, UTP, and mechanical stress (18) . Increased amounts of Up 4 A were reported to be associated with juvenile hypertension (17) . In addition, we recently discovered that Up 4 A has a potent vasoconstrictive effect on rat isolated pulmonary artery (13) . Up 4 Ainduced contraction of the pulmonary artery likely involves P2Y receptor activation, extracellular Ca 2ϩ entry, and release of Ca 2ϩ from intracellular stores, but not Ca 2ϩ sensitization via the RhoA/ROCK pathway (13) . Given that both P2X and P2Y receptors are expressed in the respiratory system, including airway epithelial and smooth muscle cells, the present study was designed to explore the potential roles of purinergic signaling in the regulation of lung functions, with a focus on the effect of Up 4 A on ASM contractility and the underlying signaling mechanisms.
MATERIALS AND METHODS

Materials.
Up4A was purchased from AXXORA (San Diego, CA). Di-inosine pentaphosphate (Ip5I), suramin, ACh, EGTA, nifedipine, and H1152, were purchased from Sigma-Aldrich Canada (Oakville, ON, Canada).
Myography. Tissue preparation was performed using a protocol modified from that previously described (13) . In brief, male SpragueDawley (SD) rats (250 -300 g), cared for in accordance with the recommendations of the Canadian Council on Animal Care, were killed by decapitation under halothane anesthesia. The protocol of animal study was approved by the Animal Care and Use Committee at the University of Calgary. The tracheal and extrapulmonary bronchi were dissected and cut into rings (ϳ2 mm in length), mounted in a myograph chamber (Danish Myo Technology, Skejbyparken, Denmark) and maintained in Krebs solution bubbled with a 95% O 2-5% CO2 gas mixture at 37°C. Isometric tension was recorded using MyoDaq 2.1 software (Danish Myo Technology). After equilibration, each ring was contracted with 1 M ACh, and isometric tension was measured. ACh was then washed out, and the tissues were reequilibrated. The effects of Up 4A on ASM in the absence and presence of inhibitors or antagonists were measured. Inhibitors or antagonists were added 10 min before application of Up4A. Isometric tension was normalized and expressed as percentage of the maximal force induced by 1 M ACh in the same preparation. In epithelium-free preparations, the epithelial layer was removed by mechanical rubbing. Tissues were frozen at the end of the experiment for histological examination to confirm actual removal of the epithelium.
Preparation of human bronchiolar rings. Human bronchiolar rings were obtained from small lung pieces of surgically removed carcinoma from Tianjin Medical University General Hospital. After surgery, small lung pieces were quickly separated from the tumor-free part of each lung tissue and transferred to the laboratory in ice-cold physiological salt solution, and segments of human bronchioles (ϳ1 mm in diameter) were carefully dissected under microscopy. Segments were cut into small rings (ϳ2 mm in length) for isometric force measurements. Experiments using human tissues, which had the consent of all patients, were performed in accordance with the protocols approved by the Ethics Committee of NanKai University and the Guidelines of Tianjin Medical University General Hospital.
Preparation of tissue RNA and RT-PCR analysis. Expression of P2X mRNAs was detected by RT-PCR analysis. The tracheal and extrapulmonary bronchi were dissected and homogenized for total RNA extraction with TRIzol Reagent (Takara Biotechnology, DaLian, China) according to the manufacturer's recommendations. RNA (1 g) was used for the first-strand cDNA synthesis using oligo(dT)15 primer (Takara Biotechnology). PCR reactions were performed with the following primers: P2X1 primers (forward: 5=-GAAAGCCCAAGGTATTCG-3=, reverse: 5=-AGTTGAAGCCTGGAGACA-3=, expected product: 455 bp), P2X2 primers (forward: 5=-TCACAGGCCATCTACTTGAG-3=, reverse: 5=-GAATCAGAGTGCAACCCCAA-3, expected product: 357 bp), P2X3 primers (forward: 5=-CAGTGGCCTGGTCACTGGCGA-3=, reverse: 5=-TGGCGTTCTGGGTATTAAGATCGG-3=, expected product: 440 bp), P2X4 primers (forward: 5=-CAGAGCACCTGTCCA-GAGATTC-3=, reverse: 5=-CACGATTGTGCCAAGACG-3=, expected product: 372 bp), P2X5 primers (forward: 5=-GCTGAGCGT-GAAGGCAT-3=, reverse: 5=-TGTTGTCCAGGCGGTT-3=, expected product: 496 bp), P2X6 primers (forward: 5=-GCTGTGCCCAG-GAAACC-3=, reverse: 5=-GAGGCTGCCCACCAGTAAT-3=, expected product: 371 bp), and P2X7 primers (forward: 5=-CCTGGCTA-CAACTTCAGATAC-3=, reverse: 5=-ACGATGGGCTCACACTTC-3=, expected product: 311 bp). Conditions for the PCR reactions were as follows: 5 min at 95°C followed by 35 cycles of 45 s at 94°C, 45 s at 55°C, 45 s at 72°C, and a final extension of 10 min at 72°C. A PCR product of smooth muscle-specific ␣-actin (243 bp) was used as an internal control, as described previously (14), because use of the ␣-actin primer pairs, which span an intron, can establish the absence of intron sequences in the RT product obtained from tissue RNA. For each RT-PCR experiment, the airway segments from one rat were processed for RNA extraction. Separate experiments were conducted three times using three animals. RT-PCR products were purified for DNA sequencing analysis (ShangHai Bioengineering, ShangHai, China).
Data analysis. Data are presented as either representative recordings or mean values Ϯ SE. The number of replicates (n) represents the number of isolated trachea or bronchioles used (one per animal). Differences were evaluated by Student's t-test (paired or unpaired) for comparison of two groups and by ANOVA for comparisons involving three or more groups, P Ͻ 0.05 was considered statistically significant.
RESULTS
Up 4 A stimulates contraction of rat isolated airways and human bronchioles.
To evaluate the effect of Up 4 A on ASM contractility, we first applied Up 4 A to preparations of rat isolated trachea and extrapulmonary bronchi. Figure 1A shows a representative tracing of the tracheal response to ACh (1 M) and Up 4 A (10 M). Application of Up 4 A elicited a moderate contractile response, which was weaker than that of ACh.
Mean data for rat trachea and right and left extrapulmonary bronchi showed that Up4A induced significant and comparable increases in tension in all airway segments (Fig. 1B , n ϭ 6, P Ͻ 0.01). Interestingly, in the same tissue, the contractile response was only repeatable for two exposures to Up 4 A, after which marked reductions in the magnitude of Up4A-induced contraction were observed (data not shown), suggesting the occurrence of a rapidly desensitizing response to Up 4 A. Therefore, it was not possible to examine the concentration-response effect of Up 4 A on ASM contraction. In addition, Up 4 A induced very similar responses in epithelium-free preparations (data not shown) to those in epithelium-intact preparations. Consistently, Up 4 A also elicited a contractile response of intrapulmo- Fig. 3 . Effect of the nonselective P2 receptor antagonist, suramin, on Up4A-induced contraction. A: representative tension tracing of a rat tracheal preparation treated with Up4A (10 M) in the absence and presence of the nonselective P2 receptor antagonist, suramin (50 M). B: mean data of Up4A-induced tension in different segments of the airway in the absence and presence of suramin. N.S. indicates that Up4A-induced tension in the presence of suramin is not significantly different from that in the absence of suramin (P Ͼ 0.05, n ϭ 5). nary bronchioles from three human subjects (Fig. 1, C and D) . In this case, the Up 4 A-induced contraction was ϳ25% of the ACh-induced contraction, and it was sustained rather than transient.
Up 4 A likely acts through P2X receptors. Extracellular nucleotides can act on plasma membrane P2X and P2Y receptors. To examine which purinergic receptor mediates the Up 4 Ainduced response, we used Ip 5 I, a P2X1 and P2X3 antagonist, and suramin, a nonselective P2X and P2Y antagonist. Preincubation with Ip 5 I (10 M), but not the vehicle (H 2 O), for 10 min significantly inhibited Up 4 A-induced contraction (Fig. 2, A and B, n ϭ 6, P Ͻ 0.01). In contrast, preincubation with suramin (50 M) did not affect Up 4 A-induced contraction (Fig. 3, A and B , n ϭ 5, P Ͼ 0.05 vs. Up 4 A alone). These results suggest that P2X, not P2Y, receptors are involved in the Up 4 A-induced response. To examine further the involvement of P2X receptors, we tested the effect of Up 4 A following desensitization of P2X receptors with the P2X receptor agonist, ␣,␤-methylene-ATP (␣,␤-MeATP). As shown in Fig. 4 , following three successive applications of ␣,␤-MeATP (10 M), the airway segments, which no longer responded to ␣,␤-MeATP, exhibited a very weak contractile response to Up 4 A (Fig. 4A) . Mean data summarizing the effect of ␣,␤-MeATP on the Up 4 A response show that, after desensitization of P2X receptors with ␣,␤-MeATP, Up 4 A-induced ASM contraction was significantly attenuated (Fig. 4B) .
Expression of P2X receptors in the airway. Experiments described above suggest that P2X receptors are likely involved in Up 4 A-induced contraction. To further explore the involvement of P2X receptors, we detected mRNA expression of P2X receptors using RT-PCR analysis. Figure 5 demonstrates that epithelium-free rat airway tissues expressed P2X1, P2X4, P2X6, and P2X7 mRNAs. In contrast, P2X3 mRNA was barely detectable, and P2X2 and P2X5 mRNAs were not detected in the airway segments. The positive controls for P2X2 and P2X5 were from mRNA of rat brain tissues. The image was a representative of three independent experiments with very similar results. PCR products of P2X1, P2X4, P2X6, and P2X7 were purified for DNA sequencing analysis. All DNA sequences (not shown) were verified by comparisons with appropriate databases in PubMed.
Roles of extracellular Ca 2ϩ and L-type Ca 2ϩ channels. To investigate the cellular mechanisms underlying the contractile effect of Up 4 A on the airway, we first assessed the involvement of extracellular Ca 2ϩ entry by examining the effect of removal of extracellular Ca 2ϩ in the presence of EGTA (a Ca 2ϩ chelating agent) on Up 4 A-induced contraction. Pretreatment with EGTA (10 mM) for 15 min abolished Up 4 A-induced contraction (Fig. 6) . This result suggests a requirement of extracellular Ca 2ϩ for Up 4 A-induced contraction. To determine whether extracellular Ca 2ϩ entry involves L-type Ca 2ϩ channels, we examined the effect of Up 4 A in the presence of the L-type Ca 2ϩ channel blocker, nifedipine. Preincubation with nifedipine (1 M) completely prevented the Up 4 A-induced response in all segments of the airway (Fig. 7) .
Role of Ca 2ϩ sensitization via the RhoA/ROCK pathway. A Ca 2ϩ sensitization mechanism has been implicated in the Fig. 5 . Expression of P2X receptors in rat airway smooth muscle. After removal of the epithelial tissues, isolated tracheal and extrapulmonary bronchial segments from rats were used for RNA extraction. Expression of P2X mRNA was detected by RT-PCR as described in MATERIALS AND METHODS.
Smooth muscle-specific ␣-actin was used as an internal RT-PCR control. The image is representative of 3 independent experiments. regulation of ASM contraction. Specifically, Ca 2ϩ sensitization via activation of the RhoA/ROCK pathway has been implicated in P2X receptor-mediated ASM contraction (16, 27) . To determine whether Ca 2ϩ sensitization mediates Up 4 A-induced contraction, we examined the effect of H1152, an inhibitor of ROCK, on the Up 4 A-induced response. As shown in Fig. 8 , the presence of H1152 (1 M) markedly inhibited Up 4 A-induced contraction (n ϭ 5, P Ͻ 0.01).
DISCUSSION
The present study demonstrated that Up 4 A induced contraction of rat isolated airways. Importantly, Up 4 A also induced a contractile response in human intrapulmonary bronchioles. Extracellular nucleotides generate their cellular responses by acting on membrane P2X or P2Y receptors. ATP induces ASM contraction via either P2X receptors (9, 25) or P2Y receptors (4, 8) . Up 4 A can potentially activate P2X and P2Y receptors because of its purine and pyrimidine moieties. We previously observed that Up 4 A stimulates a potent contractile response in the rat isolated pulmonary artery, likely through P2Y receptors (13) . The present study demonstrated that Up 4 A-induced contraction of the rat isolated airway was through P2X receptors because it was prevented by either inhibition of P2X receptors with Ip 5 I or desensitization of P2X receptors with ␣,␤-MeATP. Because Ip 5 I mainly inhibits rat P2X1 and P2X3 receptors (11, 20) and among the P2X receptor subfamily only P2X1 and P2X3 receptors desensitize rapidly after simulation (29), P2X1 and P2X3 receptors are most likely to mediate the Up 4 A response. However, P2X3 receptor is expressed predominantly in the nervous system, not in smooth muscle (29) , consistent with our observation that P2X3 mRNA was barely detectable in ASM. Therefore, it is most likely that the P2X1 receptor mediates Up 4 A-induced contraction of ASM. This conclusion was also supported by the observation in the present study that the Up4A-induced contraction was not affected by suramin, which is most effective toward the subfamilies of P2X2, P2X5, P2Y2, and P2Y11 receptors (6) .
The mechanisms underlying extracellular nucleotide-induced airway contraction involve an increase in [Ca 2ϩ ] i . It has been shown that ATP stimulates ASM contraction through regulation of Ca 2ϩ influx (9, 25 (25) .
Contraction of ASM is also regulated by enhanced sensitivity to Ca 2ϩ of the contractile elements through RhoA/ROCK activation (16, 22, 33, 34, 38) . Studies also suggest an involvement of the RhoA/ROCK pathway in P2X receptor-mediated ASM contraction (16, 27) . The present study demonstrated that the selective ROCK inhibitor, H1152, significantly inhibited Up 4 A-induced contraction, suggesting the involvement of this Ca 2ϩ sensitization pathway. The relationship between Ca 2ϩ and the RhoA/ROCK pathway in Up 4 A-induced ASM contraction remains unclear because the RhoA/ROCK pathway may be activated by Ca 2ϩ -dependent (15, 16) and Ca 2ϩ -independent mechanisms (2, 16, 19) . In contrast, the RhoA/ ROCK pathway can modify the [Ca 2ϩ ] i response in guinea pig trachea (16) .
In conclusion, Up 4 A-induced ASM contraction is likely mediated by the P2X1 receptor, Ca 2ϩ entry via VDCCs, and Ca 2ϩ sensitization through activation of the RhoA/ROCK pathway. Although the physiological role of Up 4 A in the respiratory system remains to be identified, the present study will lead to a better understanding of the pathophysiological roles of extracellular nucleotides in the lung and may help to identify potential therapeutic targets in the treatment of pulmonary dysfunctions. 
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